ADDING INSULIN GLARGINE TO ORAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES RESULTS IN LONGER PERSISTENCE WITH TREATMENT COMPARED TO NPH INSULIN

被引：1
|
作者：
Pfohl, M. [1 ]
Dippel, F. W. [2 ]
Kostev, K. [3 ]
Kotowa, W. [4 ]
机构：
[1] Evangel Bethesda Johanniter Klinikum GmbH, Duisburg, Germany
[2] Sanofi Aventis Germany GmbH, Berlin, Germany
[3] IMS HEALTH GmbH & Co, OHG, Frankfurt, Germany
[4] IMS HEALTH, Nurnberg, Germany
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66691-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A509 / A510
页数：2
相关论文
共 50 条
  • [1] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Pan, Chang-Yu
    Sinnassamy, Patrick
    Chung, Kab-Do
    Kim, Kwang-Won
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
  • [2] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
    Terres, CR
    Rodríguez, J
    Bolinder, B
    De Pablos, P
    [J]. DIABETES, 2004, 53 : A291 - A291
  • [3] Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin
    Quinzler, Renate
    Ude, Miriam
    Franzmann, Alexandra
    Feldt, Sandra
    Schuessell, Katrin
    Leuner, Kristina
    Mueller, Walter E.
    Dippel, Franz-Werner
    Schulz, Martin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (01) : 24 - 32
  • [4] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
    Terrés, CR
    Rodríguez, J
    Bolinder, B
    de Pablos, P
    [J]. DIABETOLOGIA, 2004, 47 : A345 - A345
  • [5] Economic evaluation of the use of insulin glargine compared with NPH insulin in patients with Type 2 diabetes in Spain
    Rodríguez, J
    Terrés, CR
    Bolinder, B
    de Pablos, P
    [J]. DIABETOLOGIA, 2004, 47 : A344 - A344
  • [6] Higher Persistence with Basal Supported Oral Therapy (BOT) with Insulin Glargine Compared to NPH Insulin Therapy Combined with Oral Antidiabetics
    Pfohl, M.
    Dippel, F. -W.
    Kostev, K.
    Maltz, A.
    Kotowa, W.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2009, 4 (03) : 166 - 171
  • [7] EFFECT OF INSULIN GLARGINE OR NPH INSULIN ON TREATMENT SATISFACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Moock, J.
    Hessel, F.
    Kohlmann, T.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A514 - A514
  • [8] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    [J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [9] Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes.
    Fonseca, V
    Bell, D
    Mecca, T
    [J]. DIABETOLOGIA, 2001, 44 : A207 - A207
  • [10] Treatment to target in Type 2 diabetes: consistent risk reduction of hypoglycaemia with basal insulin glargine as compared with NPH insulin in insulin-naive patients on oral agents.
    Rosenstock, J
    Riddle, M
    [J]. DIABETOLOGIA, 2002, 45 : A259 - A259
12345